Dermamelan®
patented hyperpigmentation treatment method
Dermamelan® is a patented method for treating hyperpigmentation, designed to reduce melanin overproduction and prevent the formation of new pigment spots over the long term. This approach is based on scientific and clinical research conducted in collaboration with leading dermatology clinics and specialists.
Intensive treatment for complex hyperpigmentation
Dermamelan® is a specific and intensive therapeutic method developed to treat and manage even the most complex forms of hyperpigmentation. It is administered exclusively under the supervision of a specialist.
This procedure not only eliminates hyperpigmentation but also acts at the cellular level by inhibiting melanin production. Dermamelan® targets melanocyte cells directly, controlling various pigmentation mechanisms. These include slowing melanin synthesis, inhibiting the transfer of melanin from melanocytes to keratinocytes, reducing the activity of melanin-stimulating enzymes, and minimizing inflammatory and vascular reactions that contribute to the development of hyperpigmentation.
Dermamelan® is also effective in cases of unwanted pigmentation caused by inflammatory skin conditions such as acne or other traumas.